Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Research suggests that Lipopolysaccharides (LPS), when translocated from the gut into the bloodstream, may contribute to the development of cardiovascular diseases (CVD) by triggering inflammatory responses and promoting atherosclerosis.
A study published in Nature Reviews Cardiology indicates that Lipopolysaccharides (LPS), present in the gut, can cause non-septic, low-grade endotoxemia, which is associated with systemic inflammation and has been suggested to play a pivotal role in atherothrombosis
Violi et al. 2023 Nat Rev Cardiol 20: 24-3…